Literature DB >> 25464914

Chemokine receptors and cortical interneuron dysfunction in schizophrenia.

David W Volk1, Anjani Chitrapu2, Jessica R Edelson2, David A Lewis3.   

Abstract

Alterations in inhibitory (GABA) neurons, including deficiencies in the GABA synthesizing enzyme GAD67, in the prefrontal cortex in schizophrenia are pronounced in the subpopulations of neurons that contain the calcium-binding protein parvalbumin or the neuropeptide somatostatin. The presence of similar illness-related deficits in the transcription factor Lhx6, which regulates prenatal development of parvalbumin and somatostatin neurons, suggests that cortical GABA neuron dysfunction may be related to disturbances in utero. Since the chemokine receptors CXCR4 and CXCR7 guide the migration of cortical parvalbumin and somatostatin neurons from their birthplace in the medial ganglionic eminence to their final destination in the neocortex, we sought to determine whether altered CXCR4 and/or CXCR7 mRNA levels were associated with disturbances in GABA-related markers in schizophrenia. Quantitative PCR was used to quantify CXCR4 and CXCR7 mRNA levels in the prefrontal cortex of 62 schizophrenia and 62 healthy comparison subjects that were previously characterized for markers of parvalbumin and somatostatin neurons and in antipsychotic-exposed monkeys. We found elevated mRNA levels for CXCR7 (+29%; p<.0001) and CXCR4 (+14%, p=.052) in schizophrenia subjects but not in antipsychotic-exposed monkeys. CXCR7 mRNA levels were inversely correlated with mRNA levels for GAD67, parvalbumin, somatostatin, and Lhx6 in schizophrenia but not in healthy subjects. These findings suggest that higher mRNA levels for CXCR7, and possibly CXCR4, may represent a compensatory mechanism to sustain the migration and correct positioning of cortical parvalbumin and somatostatin neurons in the face of other insults that disrupt the prenatal development of cortical GABA neurons in schizophrenia.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  GABA; GAD67; Parvalbumin; Postmortem; Prenatal development; Somatostatin

Mesh:

Substances:

Year:  2014        PMID: 25464914      PMCID: PMC4427549          DOI: 10.1016/j.schres.2014.10.031

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  43 in total

1.  Cortical deficits of glutamic acid decarboxylase 67 expression in schizophrenia: clinical, protein, and cell type-specific features.

Authors:  Allison A Curley; Dominique Arion; David W Volk; Josephine K Asafu-Adjei; Allan R Sampson; Kenneth N Fish; David A Lewis
Journal:  Am J Psychiatry       Date:  2011-06-01       Impact factor: 18.112

2.  Altered parvalbumin basket cell inputs in the dorsolateral prefrontal cortex of schizophrenia subjects.

Authors:  J R Glausier; K N Fish; D A Lewis
Journal:  Mol Psychiatry       Date:  2013-11-12       Impact factor: 15.992

3.  Higher gamma-aminobutyric acid neuron density in the white matter of orbital frontal cortex in schizophrenia.

Authors:  Dipesh Joshi; Samantha J Fung; Alice Rothwell; Cynthia Shannon Weickert
Journal:  Biol Psychiatry       Date:  2012-07-25       Impact factor: 13.382

4.  Directed migration of cortical interneurons depends on the cell-autonomous action of Sip1.

Authors:  Veronique van den Berghe; Elke Stappers; Bram Vandesande; Jordane Dimidschstein; Roel Kroes; Annick Francis; Andrea Conidi; Flore Lesage; Ruben Dries; Silvia Cazzola; Geert Berx; Nicoletta Kessaris; Pierre Vanderhaeghen; Wilfred van Ijcken; Frank G Grosveld; Steven Goossens; Jody J Haigh; Gord Fishell; André Goffinet; Stein Aerts; Danny Huylebroeck; Eve Seuntjens
Journal:  Neuron       Date:  2013-01-09       Impact factor: 17.173

5.  Dlx1&2-dependent expression of Zfhx1b (Sip1, Zeb2) regulates the fate switch between cortical and striatal interneurons.

Authors:  Gabriel L McKinsey; Susan Lindtner; Brett Trzcinski; Axel Visel; Len A Pennacchio; Danny Huylebroeck; Yujiro Higashi; John L R Rubenstein
Journal:  Neuron       Date:  2013-01-09       Impact factor: 17.173

6.  Lhx6 directly regulates Arx and CXCR7 to determine cortical interneuron fate and laminar position.

Authors:  Daniel Vogt; Robert F Hunt; Shyamali Mandal; Magnus Sandberg; Shanni N Silberberg; Takashi Nagasawa; Zhengang Yang; Scott C Baraban; John L R Rubenstein
Journal:  Neuron       Date:  2014-04-16       Impact factor: 17.173

Review 7.  Early developmental disturbances of cortical inhibitory neurons: contribution to cognitive deficits in schizophrenia.

Authors:  David W Volk; David A Lewis
Journal:  Schizophr Bull       Date:  2014-07-22       Impact factor: 9.306

8.  Deficits in transcriptional regulators of cortical parvalbumin neurons in schizophrenia.

Authors:  David W Volk; Takurou Matsubara; Siyu Li; Elizabeth J Sengupta; Danko Georgiev; Yoshio Minabe; Allan Sampson; Takanori Hashimoto; David A Lewis
Journal:  Am J Psychiatry       Date:  2012-10       Impact factor: 18.112

9.  Endocannabinoid metabolism in the prefrontal cortex in schizophrenia.

Authors:  David W Volk; Benjamin I Siegel; Christopher D Verrico; David A Lewis
Journal:  Schizophr Res       Date:  2013-04-02       Impact factor: 4.939

10.  The LIM homeodomain protein Lhx6 regulates maturation of interneurons and network excitability in the mammalian cortex.

Authors:  Guilherme Neves; Mala M Shah; Petros Liodis; Angeliki Achimastou; Myrto Denaxa; Grant Roalfe; Abdul Sesay; Matthew C Walker; Vassilis Pachnis
Journal:  Cereb Cortex       Date:  2012-06-17       Impact factor: 5.357

View more
  21 in total

Review 1.  Interneuron epigenomes during the critical period of cortical plasticity: Implications for schizophrenia.

Authors:  Hirofumi Morishita; Marija Kundakovic; Lucy Bicks; Amanda Mitchell; Schahram Akbarian
Journal:  Neurobiol Learn Mem       Date:  2015-04-04       Impact factor: 2.877

2.  Altered Markers of Cortical γ-Aminobutyric Acid Neuronal Activity in Schizophrenia: Role of the NARP Gene.

Authors:  Sohei Kimoto; Mark M Zaki; H Holly Bazmi; David A Lewis
Journal:  JAMA Psychiatry       Date:  2015-08       Impact factor: 21.596

3.  Characterization of genome-wide association study data reveals spatiotemporal heterogeneity of mental disorders.

Authors:  Yulin Dai; Timothy D O'Brien; Guangsheng Pei; Zhongming Zhao; Peilin Jia
Journal:  BMC Med Genomics       Date:  2020-12-28       Impact factor: 3.063

4.  The Cytokine CXCL12 Promotes Basket Interneuron Inhibitory Synapses in the Medial Prefrontal Cortex.

Authors:  Pei-Rung Wu; Kathleen K A Cho; Daniel Vogt; Vikaas S Sohal; John L R Rubenstein
Journal:  Cereb Cortex       Date:  2017-09-01       Impact factor: 5.357

5.  Cortical GABA markers identify a molecular subtype of psychotic and bipolar disorders.

Authors:  D W Volk; A R Sampson; Y Zhang; J R Edelson; D A Lewis
Journal:  Psychol Med       Date:  2016-06-22       Impact factor: 7.723

Review 6.  Cortical interneuron development: a tale of time and space.

Authors:  Jia Sheng Hu; Daniel Vogt; Magnus Sandberg; John L Rubenstein
Journal:  Development       Date:  2017-11-01       Impact factor: 6.868

7.  JNK signaling is required for proper tangential migration and laminar allocation of cortical interneurons.

Authors:  Abigail K Myers; Jessica G Cunningham; Skye E Smith; John P Snow; Catherine A Smoot; Eric S Tucker
Journal:  Development       Date:  2020-01-17       Impact factor: 6.868

8.  Pathological Basis for Deficient Excitatory Drive to Cortical Parvalbumin Interneurons in Schizophrenia.

Authors:  Daniel W Chung; Kenneth N Fish; David A Lewis
Journal:  Am J Psychiatry       Date:  2016-07-22       Impact factor: 18.112

9.  Altered expression of developmental regulators of parvalbumin and somatostatin neurons in the prefrontal cortex in schizophrenia.

Authors:  David W Volk; Jessica R Edelson; David A Lewis
Journal:  Schizophr Res       Date:  2016-03-10       Impact factor: 4.939

10.  The Role of the Nuclear Factor-κB Transcriptional Complex in Cortical Immune Activation in Schizophrenia.

Authors:  David W Volk; Annie E Moroco; Kaitlyn M Roman; Jessica R Edelson; David A Lewis
Journal:  Biol Psychiatry       Date:  2018-06-28       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.